Stocks Comparison
Davita vs NewGenIvf: revenue, profit, margins and growth compared
Davita brought in $13.6B of revenue in fiscal 2025, NewGenIvf $23.7M in fiscal 2025. Revenue changed by +6.5% at Davita and +336.3% at NewGenIvf on the year before, so NewGenIvf grew faster. Davita kept 5.5% of its revenue as net profit, NewGenIvf 41.7%. Free cash flow was $1.3B at Davita and -$11.1M at NewGenIvf.
Side by side, latest fiscal year
| DVA | NIVF | |
|---|---|---|
| Fiscal year ended | FY2025 (December 31, 2025) | FY2025 (December 31, 2025) |
| Revenue | $13.6B | $23.7M |
| Revenue growth | +6.5% | +336.3% |
| Net income | $746.8M | $9.9M |
| Net margin | 5.5% | 41.7% |
| Free cash flow | $1.3B | -$11.1M |
| Free cash flow margin | 9.6% | -46.7% |
| Earnings per share (diluted) | $9.84 | $3.04 |
| Cash | $676.4M | $758.6K |
| Debt | $10.3B | n/a |
| Price to earnings | 18.1 | n/a |
| Market value | $11.4B | $3.3M |
| Dividend yield | n/a | n/a |
| Rank by revenue in sector | #37 of 646 · Health care | #425 of 646 · Health care |
Over the years
Questions about Davita and NewGenIvf
Which is bigger by revenue, Davita or NewGenIvf?
Davita is bigger by revenue: $13.6B in fiscal 2025, against $23.7M for NewGenIvf in fiscal 2025.
Which keeps more of its revenue as profit, Davita or NewGenIvf?
Davita had a net margin of 5.5% in fiscal 2025; NewGenIvf had 41.7% in fiscal 2025.
Which grew revenue faster, Davita or NewGenIvf?
In their latest fiscal years revenue changed by +6.5% at Davita and +336.3% at NewGenIvf.
Where do these numbers come from?
From the annual reports each company files with the SEC (10-K, or 20-F and 40-F for foreign companies), read from their XBRL data. Margins and growth are simple arithmetic on those figures. Nothing here is a recommendation.